CLC and osteosarcoma: Furthermore, while CLC in silico predictions indicated the potential of compounds 5a and 5b to induce cytotoxic effects in melanoma cells, but not in osteosarcoma cells, we observed that, experimentally, their activity is reversed, being effective on MG‐63 osteosarcoma cell line, but not on MeWo melanoma cells.